Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20192724rdf:typepubmed:Citationlld:pubmed
pubmed-article:20192724lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0023787lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0178719lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0039082lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0887947lld:lifeskim
pubmed-article:20192724lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:20192724pubmed:issue7lld:pubmed
pubmed-article:20192724pubmed:dateCreated2010-3-5lld:pubmed
pubmed-article:20192724pubmed:abstractTextThe link between human immunodeficiency virus/highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome (HALS) and the use of thymidine analogues has been well established. However, to our knowledge, no relationship has been proven between intracellular levels of stavudine (d4T) and HALS.lld:pubmed
pubmed-article:20192724pubmed:languageenglld:pubmed
pubmed-article:20192724pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20192724pubmed:citationSubsetIMlld:pubmed
pubmed-article:20192724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20192724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20192724pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20192724pubmed:statusMEDLINElld:pubmed
pubmed-article:20192724pubmed:monthAprlld:pubmed
pubmed-article:20192724pubmed:issn1537-6591lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:DomingoPerePlld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:BaigetMontser...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:VillarroyaFra...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:PruvostAlainAlld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:VidalFrancesc...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:SalazarJulian...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:FernandezIren...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:DomingoJoan...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:CabezaMaria...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:GutierrezMari...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:MateoMaria...lld:pubmed
pubmed-article:20192724pubmed:authorpubmed-author:MuñozJessicaJlld:pubmed
pubmed-article:20192724pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20192724pubmed:day1lld:pubmed
pubmed-article:20192724pubmed:volume50lld:pubmed
pubmed-article:20192724pubmed:ownerNLMlld:pubmed
pubmed-article:20192724pubmed:authorsCompleteYlld:pubmed
pubmed-article:20192724pubmed:pagination1033-40lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:meshHeadingpubmed-meshheading:20192724...lld:pubmed
pubmed-article:20192724pubmed:year2010lld:pubmed
pubmed-article:20192724pubmed:articleTitleRelationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens.lld:pubmed
pubmed-article:20192724pubmed:affiliationInfectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain. pdomingo@santpau.catlld:pubmed
pubmed-article:20192724pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20192724pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20192724lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20192724lld:pubmed